Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2005
10/12/2005CN1222520C Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
10/12/2005CN1222519C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/12/2005CN1222507C Process for production of calcium pantothenate
10/12/2005CN1222374C Extrusion die
10/12/2005CN1222303C Traditional Chinese medicine wine fore relaxing muscles and tendons and activating blood circulation, expelling wind and stopping pain, and relieving flatulence and relaxing the bowels
10/12/2005CN1222295C Neutrophil leucocyte functional inhibitor
10/12/2005CN1222288C Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
10/12/2005CN1222286C Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor
10/12/2005CN1222284C High lipid diet
10/12/2005CN1222280C Topical plaster with non-steroidal antirheumatic agents with an acid group
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953838 Urocortin-III and uses thereof
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953809 Monocyte chemoattractant protein-1 inhibitor compounds
10/11/2005US6953804 alkenyl ether functionality at 1-position; immunomodulators that induce cytokine biosynthesis; 1-[2-(2-Propynyloxy)ethyl]-1H-imidazo[4,5-c]quinolin-4-amine;
10/11/2005US6953803 Pyrimidine compounds
10/11/2005US6953802 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
10/11/2005US6953798 compounds are able to inhibit binding of alpha 4 integrins to their ligands and are of use in prophylaxis and treatment of immune or inflammatory disorders
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/11/2005US6953796 Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
10/11/2005US6953795 N-[5-[[3[-(morpholin-4-yl)carbonyl]phenyl]thio]thiazol-2-yl]-4-(N,N-dimethylamino)benzamide; may be combined with antiinflammatory, antiarthritic, antiproliferative, anticancer, anti-cytotoxic or antiallergenic agents
10/11/2005US6953793 For therapy of autoimmune diseases mediated by cathepsin S; for inhibiting the progression of tissue transplant rejection
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/11/2005US6953776 Ophthalmic formulations
10/11/2005US6953591 Administering to a mammal non-toxic effective T-cell function-mediated disorder-treating amount of phosphatidyl serine (PS) carrying bodies wherein progression of T-cell function-mediated disorder is inhibited
10/06/2005WO2005093067A1 Decoy nucleic acid to synoviolin gene promoter
10/06/2005WO2005093066A1 Marker gene for arthrorheumatism test
10/06/2005WO2005093064A1 Novel galectin 9 modification protein and use thereof
10/06/2005WO2005092898A1 The conjugates of a hydrophilic polymer-tripterygium's extracts and the pharmaceutical compositions thereof
10/06/2005WO2005092322A1 Natural compound causing rar activation
10/06/2005WO2005092320A1 Cytoprotective composition
10/06/2005WO2005092265A1 Pasting agent
10/06/2005US20050223416 C1 inhibitor produced in the milk of transgenic mammals
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222418 Novel tyloindicines and related processes, pharmaceutical compositions and methods
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222410 Inhibitors of histone deacetylase
10/06/2005US20050222395 New peptide derivatives
10/06/2005US20050222387 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/06/2005US20050222253 Anti-cancer nitro- and thia-fatty acids
10/06/2005US20050222251 Dual inhibition of cyclooxygenase-2 and carbonic anhydrase
10/06/2005US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/06/2005US20050222238 Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
10/06/2005US20050222226 N-[3-(2-Aminoethyl)-4-(4-bromophenyl)thiazol-2(3H)-ylidene]aniline; antiinflammatory agents, antiallergens; inhibit infiltration of leukocytes such as eosinophils and lymphocytes; autoimmune diseases, asthma
10/06/2005US20050222224 p53 Inhibitors and therapeutic use of the same
10/06/2005US20050222221 Cell differentiation, regeneration of pancreas epithelial cells to insulin producing beta cells; administering a dipeptidyl-peptidase activators
10/06/2005US20050222216 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
10/06/2005US20050222205 Treatment of pain with ifendropil
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222196 Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
10/06/2005US20050222194 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction
10/06/2005US20050222189 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
10/06/2005US20050222160 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
10/06/2005US20050222153 Tyrosine kinase enzyme inhibitors as growth factor receptors and useful as antiproliferation agents
10/06/2005US20050222152 Enzyme inhibitors for disease treatment with Cathepsin s
10/06/2005US20050222147 Process for the preparation of morpholine derivatives and intermediates therefore
10/06/2005US20050222143 Helix mimetics and composition and methods related thereto
10/06/2005US20050222136 Active substance combination
10/06/2005US20050222118 For therapy of inflammatory or allergic condition
10/06/2005US20050222099 Pregnane steroids for use in the treatment of cns disorders
10/06/2005US20050222091 Use of tyrosine kinase inhibitors for treating cns disorders
10/06/2005US20050222011 Selectin ligands
10/06/2005US20050222001 Stable foamed compositions
10/06/2005US20050221368 Methods for identifying RNA binding compounds
10/06/2005US20050221347 Inhibitors of binding between proteins and macromolecular ligands
10/06/2005US20050221317 Use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
10/06/2005US20050221284 Heteropolymer complexes and methods for their use
10/06/2005US20050220906 Pharmaceutical composition for treating rheumatism and the preparation thereof
10/06/2005US20050220894 Colostrum-based composition
10/06/2005US20050220861 Colonic release compostion
10/06/2005US20050220823 Ophthalmic composition comprising ascomycin
10/06/2005US20050220806 Method of transporting physiological polymer using protein having rxp repeated sequence
10/06/2005US20050220804 Increasing an immune response in an animal, comprising administering a compound (such as a carbohydrate, an antibiotic, a sugar, a protein, or an antibody) that binds a C-type lectin (but not the DEC-205 receptor) on the surface of a dendritic cell
10/06/2005US20050220790 Amino-terminally truncated rantes as chemokine antagonists
10/06/2005US20050220784 Quinazoline derivatives as medicaments
10/06/2005US20050220759 Treating multiple sclerosis by orally administering an excipient and a RANTES polypeptide or a macrophage inflammatory protein; preventing autoimmune and inflammatory diseases and bacterial and viral infections
10/06/2005US20050220757 Chemokine mutants acting as chemokine antagonists
10/06/2005US20050220726 Use of sugar esters in cosmetic and/or pharmaceutical preparations
10/06/2005CA2561696A1 Novel modified galectin 9 proteins and use thereof
10/06/2005CA2561502A1 Marker gene for arthrorheumatism test
10/06/2005CA2561117A1 Decoy nucleic acid to synoviolin gene promoter
10/06/2005CA2560700A1 Tetrahydrocarbazoles and derivatives
10/06/2005CA2554074A1 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain
10/05/2005EP1582586A1 Apoptosis-associated protein and use thereof
10/05/2005EP1582521A1 Fused furan compound
10/05/2005EP1582520A1 Novel parp inhibitors
10/05/2005EP1582517A1 Blood-brain barrier disruption inhibitors
10/05/2005EP1582210A2 Compositions and methods for treating or preventing surgical adhesions
10/05/2005EP1581616A2 Novel proteins and nucleic acids encoding same
10/05/2005EP1581532A1 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
10/05/2005EP1581529A1 Benzoxazines and derivatives thereof as inhibitors of pi3ks
10/05/2005EP1581521A1 Fused heterocyclic derivatives as ppar modulators
10/05/2005EP1581517A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581511A1 Ccr8 inhibitors
10/05/2005EP1581491A1 Indole derivatives as ppar modulators
10/05/2005EP1581484A1 Hydroxamic acid derivatives having anti-inflammatory action
10/05/2005EP1581478A1 Dhodh-inhibitors and method for their identification
10/05/2005EP1581477A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
10/05/2005EP1581474A1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases
1 ... 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 ... 1272